Dennis E. Hruby

11.5k total citations · 1 hit paper
212 papers, 7.7k citations indexed

About

Dennis E. Hruby is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, Dennis E. Hruby has authored 212 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Virology, 94 papers in Epidemiology and 86 papers in Molecular Biology. Recurrent topics in Dennis E. Hruby's work include Poxvirus research and outbreaks (133 papers), Herpesvirus Infections and Treatments (79 papers) and Virus-based gene therapy research (75 papers). Dennis E. Hruby is often cited by papers focused on Poxvirus research and outbreaks (133 papers), Herpesvirus Infections and Treatments (79 papers) and Virus-based gene therapy research (75 papers). Dennis E. Hruby collaborates with scholars based in United States, Belgium and France. Dennis E. Hruby's co-authors include Douglas W. Grosenbach, Christine A. Franke, Robert Jordan, Tové C. Bolken, Chelsea M. Byrd, L. Andrew Ball, Judy K. VanSlyke, Kevin F. Jones, Kady M. Honeychurch and Scott L. Weinrich and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Dennis E. Hruby

212 papers receiving 7.2k citations

Hit Papers

Oral Tecovirimat for the Treatment of Smallpox 2018 2026 2020 2023 2018 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis E. Hruby United States 53 4.5k 3.6k 3.4k 1.7k 1.1k 212 7.7k
R. Mark L. Buller United States 51 4.5k 1.0× 4.6k 1.3× 3.4k 1.0× 2.6k 1.5× 598 0.6× 148 10.2k
Marc Girard France 46 2.7k 0.6× 1.8k 0.5× 3.0k 0.9× 824 0.5× 727 0.7× 215 8.2k
Volker M. Vogt United States 47 2.8k 0.6× 1.2k 0.3× 4.4k 1.3× 1.5k 0.9× 989 0.9× 129 7.5k
Patricia L. Earl United States 54 7.0k 1.6× 3.6k 1.0× 3.0k 0.9× 1.4k 0.8× 427 0.4× 131 9.4k
Thomas R. Fuerst United States 33 1.8k 0.4× 2.9k 0.8× 2.5k 0.8× 1.5k 0.9× 310 0.3× 74 8.0k
Erna Geessien Kroon Brazil 41 2.2k 0.5× 2.3k 0.6× 1.4k 0.4× 737 0.4× 986 0.9× 284 6.3k
Samuel Dales Canada 48 2.0k 0.5× 2.1k 0.6× 2.2k 0.7× 2.6k 1.5× 767 0.7× 144 6.7k
Bernhard Dietzschold United States 61 5.7k 1.3× 4.0k 1.1× 2.2k 0.7× 1.5k 0.9× 272 0.3× 169 9.5k
Jonathan Leis United States 46 3.2k 0.7× 1.2k 0.3× 3.8k 1.1× 1.1k 0.6× 822 0.8× 108 6.8k
Stephen Oroszlan United States 59 4.9k 1.1× 2.1k 0.6× 4.5k 1.3× 2.3k 1.3× 646 0.6× 197 11.2k

Countries citing papers authored by Dennis E. Hruby

Since Specialization
Citations

This map shows the geographic impact of Dennis E. Hruby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis E. Hruby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis E. Hruby more than expected).

Fields of papers citing papers by Dennis E. Hruby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis E. Hruby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis E. Hruby. The network helps show where Dennis E. Hruby may publish in the future.

Co-authorship network of co-authors of Dennis E. Hruby

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis E. Hruby. A scholar is included among the top collaborators of Dennis E. Hruby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis E. Hruby. Dennis E. Hruby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mucker, Eric M., Arthur J. Goff, Joshua D. Shamblin, et al.. (2013). Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox). Antimicrobial Agents and Chemotherapy. 57(12). 6246–6253. 75 indexed citations
3.
Smith, Scott K., Sonja Weiss, Darin S. Carroll, et al.. (2011). Effective Antiviral Treatment of Systemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected with Monkeypox Virus. Journal of Virology. 85(17). 9176–9187. 67 indexed citations
4.
Jordan, Robert, Arthur J. Goff, Michael L. Corrado, et al.. (2009). ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification. Antimicrobial Agents and Chemotherapy. 53(5). 1817–1822. 108 indexed citations
5.
Chen, Yali, Kady M. Honeychurch, Guang Yang, et al.. (2009). Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis. Virology Journal. 6(1). 44–44. 58 indexed citations
6.
Smith, Scott K., Victoria A. Olson, Kevin L. Karem, et al.. (2008). In Vitro Efficacy of ST246 against Smallpox and Monkeypox. Antimicrobial Agents and Chemotherapy. 53(3). 1007–1012. 69 indexed citations
7.
Alzhanova, Dina & Dennis E. Hruby. (2006). A trans -Golgi Network Resident Protein, golgin-97, Accumulates in Viral Factories and Incorporates into Virions during Poxvirus Infection. Journal of Virology. 80(23). 11520–11527. 20 indexed citations
8.
Honeychurch, Kady M., Chelsea M. Byrd, & Dennis E. Hruby. (2006). Mutational analysis of the potential catalytic residues of the VV G1L metalloproteinase. Virology Journal. 3(1). 7–7. 7 indexed citations
9.
Byrd, Chelsea M. & Dennis E. Hruby. (2005). Development of an in vitro cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity. Virology Journal. 2(1). 63–63. 15 indexed citations
10.
Byrd, Chelsea M., Tové C. Bolken, Adnan M.M. Mjalli, et al.. (2004). New Class of Orthopoxvirus Antiviral Drugs That Block Viral Maturation. Journal of Virology. 78(22). 12147–12156. 45 indexed citations
11.
Warren, Travis K., Susan Amanda Lund, Kevin F. Jones, & Dennis E. Hruby. (2004). Development of PLEX, a plasmid-based expression system for production of heterologous gene products by the gram-positive bacteria Streptococcus gordonii. Protein Expression and Purification. 40(2). 319–326. 3 indexed citations
12.
Grosenbach, Douglas W., Scott G. Hansen, & Dennis E. Hruby. (2000). Identification and Analysis of Vaccinia Virus Palmitylproteins. Virology. 275(1). 193–206. 31 indexed citations
13.
Bolken, Tové C., et al.. (2000). Expression and Purification of Histidine-Tagged Proteins from the Gram-Positive Streptococcus gordonii SPEX System. Protein Expression and Purification. 20(1). 112–123. 7 indexed citations
14.
Martin, Karen H., Christine A. Franke, & Dennis E. Hruby. (1999). Novel acylation of poxvirus A-type inclusion proteins. Virus Research. 60(2). 147–157. 11 indexed citations
15.
Lee, Pei-Yu & Dennis E. Hruby. (1995). Analysis of the Role of the Amino-Terminal Peptide of Vaccinia Virus Structural Protein Precursors during Proteolytic Processing. Virology. 207(1). 229–233. 7 indexed citations
16.
Tamin, Azaibi, et al.. (1990). Anchoring a vaccinia virus promoter in the nucleus prevents itstrans-activation by viral infection. Virus Genes. 3(4). 355–359. 2 indexed citations
18.
Edwards, Robert H., Mark Selby, William C. Mobley, et al.. (1988). Processing and Secretion of Nerve Growth Factor: Expression in Mammalian Cells with a Vaccinia Virus Vector. Molecular and Cellular Biology. 8(6). 2456–2464. 29 indexed citations
19.
Hruby, Dennis E. & Gary Thomas. (1987). Use of vaccinia virus to express biopharmaceutical products.. Pharmaceutical Research. 4(2). 92–97. 7 indexed citations
20.
Dougherty, William G., Christine A. Franke, & Dennis E. Hruby. (1986). Construction of a recombinant vaccinia virus which expresses immunoreactive plant virus proteins. Virology. 149(1). 107–113. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026